1-8 of 8
Ian W. Flinn
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Zanubrutinib in the treatment of patients with del(17p) and/or TP53 CLL/SLL: analysis across clinical studies

Open Access
Clinical Trials & Observations
Constantine S Tam, Mary Ann Anderson, Martin Simkovic, Paolo Ghia, Ian W. Flinn, Kamel Laribi, Stephen S. Opat, Gavin Cull, Talha Munir, Anders Österborg, Alessandra Tedeschi, Megan (Der Yu) Wang, Andy H. Szeto, Heather Allewelt, Tommi Salmi, Jessica Li, Linlin Xu, Kenneth Wu, Remus Vezan, Mazyar Shadman, Jennifer R. Brown
Journal: Blood Advances
Blood Adv bloodadvances.2025015986.
https://doi.org/10.1182/bloodadvances.2025015986
Published: 2025
Includes: Supplemental data
Journal Articles

Zanubrutinib is well tolerated and effective in patients with CLL/SLL intolerant of ibrutinib/acalabrutinib: updated results

Open Access
Clinical Trials & Observations
Mazyar Shadman, John M. Burke, Jennifer Cultrera, Habte A. Yimer, Syed F. Zafar, Jamal Misleh, Subramanya S. Rao, Charles M. Farber, Aileen Cohen, Hui Yao, Adam Idoine, Qi An, Ian W. Flinn, Jeff P. Sharman
Journal: Blood Advances
Blood Adv (2025) 9 (16): 4100–4110.
https://doi.org/10.1182/bloodadvances.2024015493
Published: 2025
Includes: Supplemental data
Journal Articles

Impact of prior CAR T-cell therapy on mosunetuzumab efficacy in patients with relapsed or refractory B-cell lymphomas

Open Access
Clinical Trials & Observations
Elise A. Chong, Elicia Penuel, Ellen B. Napier, Rachel K. Lundberg, Lihua E. Budde, Mazyar Shadman, Matthew J. Matasar, Nancy L. Bartlett, Ian W. Flinn, Francesc Bosch, Keith Fay, Andre Goy, Anita Kumar, Loretta J. Nastoupil, Michael C. Wei, Mei Wu, Shen Yin, Joseph A. Fraietta, Emeline R. Chong, Stephen J. Schuster
Journal: Blood Advances
Blood Adv (2025) 9 (4): 696–703.
https://doi.org/10.1182/bloodadvances.2024013640
Published: 2025
Includes: Supplemental data
Journal Articles

Magrolimab plus rituximab in relapsed/refractory indolent non-Hodgkin lymphoma: 3-year follow-up of a phase 1/2 trial

Free
Clinical Trials & Observations
Amitkumar Mehta, Leslie Popplewell, Graham P. Collins, Sonali M. Smith, Ian W. Flinn, Nancy L. Bartlett, Nilanjan Ghosh, Gal Hacohen-Kleiman, Yanan Huo, Linda Su-Feher, Camille Renard, Ranjana Advani, Mark Roschewski
Journal: Blood Advances
Blood Adv (2024) 8 (22): 5855–5863.
https://doi.org/10.1182/bloodadvances.2024013277
Published: 2024
Includes: Supplemental data
Journal Articles

Magrolimab plus rituximab with or without chemotherapy in patients with relapsed/refractory diffuse large B-cell lymphoma

Free
Clinical Trials & Observations
Joseph E. Maakaron, Adam Asch, Leslie Popplewell, Graham P. Collins, Ian W. Flinn, Nilanjan Ghosh, Colm Keane, Matthew Ku, Amitkumar Mehta, Mark Roschewski, Gal Hacohen-Kleiman, Yanan Huo, Yi Zhang, Camille Renard, Sonali M. Smith, Ranjana Advani
Journal: Blood Advances
Blood Adv (2024) 8 (22): 5864–5874.
https://doi.org/10.1182/bloodadvances.2024013338
Published: 2024
Includes: Supplemental data
Journal Articles

Integrated safety analysis of umbralisib, a dual PI3Kδ/CK1ε inhibitor, in relapsed/refractory lymphoid malignancies

Free
Clinical Trials & Observations
Matthew S. Davids, Owen A. O’Connor, Wojciech Jurczak, Felipe Samaniego, Timothy S. Fenske, Pier Luigi Zinzani, Manish R. Patel, Nilanjan Ghosh, Bruce D. Cheson, Enrico Derenzini, Danielle M. Brander, James A. Reeves, Wanda Knopińska-Posłuszny, John N. Allan, Tycel Phillips, Paolo F. Caimi, Ewa Lech-Maranda, John M. Burke, Richy Agajanian, Ruth Pettengell, Lori A. Leslie, Chan Y. Cheah, Gustavo Fonseca, James Essell, Julio C. Chavez, John M. Pagel, Jeff P. Sharman, Yanzhi Hsu, Hari P. Miskin, Peter Sportelli, Michael S. Weiss, Ian W. Flinn
Journal: Blood Advances
Blood Adv (2021) 5 (23): 5332–5343.
https://doi.org/10.1182/bloodadvances.2021005132
Published: 2021
Includes: Supplemental data
Journal Articles

Zanubrutinib (BGB-3111) plus obinutuzumab in patients with chronic lymphocytic leukemia and follicular lymphoma

Free
Clinical Trials & Observations
Constantine S. Tam, Hang Quach, Andrew Nicol, Xavier Badoux, Hannah Rose, H. Miles Prince, Michael F. Leahy, Richard Eek, Nicholas Wickham, Sushrut S. Patil, Jane Huang, Radha Prathikanti, Aileen Cohen, Rebecca Elstrom, William Reed, Jingjing Schneider, Ian W. Flinn
Journal: Blood Advances
Blood Adv (2020) 4 (19): 4802–4811.
https://doi.org/10.1182/bloodadvances.2020002183
Published: 2020
Journal Articles

Combinations of idelalisib with rituximab and/or bendamustine in patients with recurrent indolent non-Hodgkin lymphoma

Free
Clinical Trials & Observations
Sven de Vos, Nina D. Wagner-Johnston, Steven E. Coutre, Ian W. Flinn, Marshall T. Schreeder, Nathan H. Fowler, Jeff P. Sharman, Ralph V. Boccia, Jacqueline C. Barrientos, Kanti R. Rai, Thomas E. Boyd, Richard R. Furman, Yeonhee Kim, Wayne R. Godfrey, John P. Leonard
Journal: Blood Advances
Blood Adv (2016) 1 (2): 122–131.
https://doi.org/10.1182/bloodadvances.2016000976
Published: 2016
Includes: Supplemental data